NCT07146191View on ClinicalTrials.gov

RE104 Radiolabeled Mass Balance (hAME) Study

PHASE1RecruitingINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

August 19, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Healthy Participant Study

Interventions

DRUG

2-[14C]-RE104 for Injection

Single, subcutaneous dose of 2-\[14C\]-RE104 for Injection

Trial Locations (1)

78744

RECRUITING

PPD Inc., Austin

All Listed Sponsors

lead

Reunion Neuroscience Inc

INDUSTRY